Synopsys, Inc. $SNPS Shares Acquired by Quintet Private Bank Europe S.A.

Quintet Private Bank Europe S.A. lifted its stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) by 1.9% in the 4th quarter, Holdings Channel.com reports. The firm owned 70,202 shares of the semiconductor company’s stock after buying an additional 1,298 shares during the quarter. Synopsys comprises about 1.9% of Quintet Private Bank Europe S.A.’s portfolio, making the stock its 13th largest holding. Quintet Private Bank Europe S.A.’s holdings in Synopsys were worth $32,975,000 at the end of the most recent reporting period.

Several other hedge funds have also recently modified their holdings of the stock. Vanguard Group Inc. raised its position in Synopsys by 20.7% during the 3rd quarter. Vanguard Group Inc. now owns 18,181,185 shares of the semiconductor company’s stock worth $8,970,415,000 after buying an additional 3,120,401 shares during the last quarter. Victory Capital Management Inc. boosted its holdings in shares of Synopsys by 238.8% in the third quarter. Victory Capital Management Inc. now owns 2,824,349 shares of the semiconductor company’s stock valued at $1,393,506,000 after acquiring an additional 1,990,608 shares in the last quarter. Coatue Management LLC purchased a new stake in shares of Synopsys in the third quarter valued at about $892,605,000. Capital Research Global Investors increased its stake in shares of Synopsys by 226.6% during the third quarter. Capital Research Global Investors now owns 2,524,512 shares of the semiconductor company’s stock worth $1,245,533,000 after acquiring an additional 1,751,432 shares during the period. Finally, State Street Corp raised its holdings in Synopsys by 20.6% during the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company’s stock worth $4,322,273,000 after purchasing an additional 1,493,912 shares in the last quarter. 85.47% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. KeyCorp raised their price objective on shares of Synopsys from $575.00 to $600.00 and gave the company an “overweight” rating in a research report on Thursday, December 11th. Bank of America upgraded Synopsys from an “underperform” rating to a “neutral” rating and dropped their target price for the stock from $525.00 to $500.00 in a research report on Monday, December 8th. Wall Street Zen raised Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. The Goldman Sachs Group set a $600.00 price target on Synopsys and gave the company a “buy” rating in a report on Wednesday, February 25th. Finally, Rosenblatt Securities dropped their price objective on Synopsys from $560.00 to $530.00 and set a “buy” rating on the stock in a report on Thursday, February 26th. Eight equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $531.00.

Read Our Latest Stock Report on Synopsys

Insider Buying and Selling at Synopsys

In related news, insider Janet Lee sold 250 shares of the firm’s stock in a transaction that occurred on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the transaction, the insider directly owned 11,959 shares of the company’s stock, valued at $6,338,270. This trade represents a 2.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 0.56% of the stock is currently owned by corporate insiders.

Synopsys Price Performance

SNPS stock opened at $395.95 on Friday. The company has a market cap of $75.85 billion, a P/E ratio of 61.48, a P/E/G ratio of 3.23 and a beta of 1.15. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The company’s 50-day moving average price is $430.80 and its 200 day moving average price is $449.68. The company has a current ratio of 1.36, a quick ratio of 1.26 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.56 by $0.21. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The company had revenue of $2.41 billion during the quarter, compared to analysts’ expectations of $2.39 billion. During the same period last year, the company posted $3.03 earnings per share. The firm’s quarterly revenue was up 65.6% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, research analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.